Surfing the NASH Tsunami Podcast Artwork Image

Surfing the NASH Tsunami

SurfingNASH.com

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the NASH Tsunami podcast. #NASH #NAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL
Episodes
S4-E12.6 - From the Vault: Building a Disease Model for NASH Prevalence: Key ChallengesMarch 19, 2023
Episode artwork
S4-E12.5 - ICER Draft Report: Different Stakeholder Impacts March 19, 2023
Episode artwork
S4-E12.4 - Biopsy, Biomarkers and Assessing the Value and Pricing of New MedicationsMarch 19, 2023
Episode artwork
S4-E12.3 - Keeping Regulatory Pace with Field AdvancementsMarch 18, 2023
Episode artwork
S4-E12.2 - ICER Draft Report: Assessment of Disease Prevalence and Prospective Drug EfficacyMarch 18, 2023
Episode artwork
S4-E12.1 - Introducing the ICER Draft Report on Resmetirom and Obeticholic Acid for NASHMarch 18, 2023
Episode artwork
S4-E12 - Deep Dive: ICER Draft Report on Resmetirom and Obeticholic Acid for NASHMarch 15, 2023
Episode artwork
S4-E11.6 - From the Vault: #NASHDay 2022 Preview: SurfingNASH PredictionsMarch 12, 2023
Episode artwork
S4-E11.5 - Excitement and Trepidations: Exploring the Year Ahead in Fatty LiverMarch 12, 2023
Episode artwork
S4-E11.4 - Increasing Incidence of Type-2 Diabetes Among AdolescentsMarch 12, 2023
Episode artwork
S4-E11.3 - Fighting for Fair Regulation Around What’s Deemed “Healthy”March 11, 2023
Episode artwork
S4-E11.2 - Pricing Estimates for Imminent Drug Approvals and the Future Standard of NITsMarch 11, 2023
Episode artwork
S4-E11.1 - The Surfers Highlight What’s Happening for Fatty Liver in 2023March 11, 2023
Episode artwork
S4-E11 - The Yin and Yang of Technology and RegulationMarch 08, 2023
Episode artwork
S4-E10.5 - From the Vault: 2022 Liver Conference: Pediatric NAFLD and Liver Health EducationMarch 05, 2023
Episode artwork
S4-E10.4 - Pediatric and Adolescent Fatty Liver: Impact of Emerging Drugs and TrialsMarch 05, 2023
Episode artwork
S4-E10.3 - Pediatric and Adolescent Fatty Liver: Implementing Real World InterventionsMarch 04, 2023
Episode artwork
S4-E10.2 - Pediatric and Adolescent Fatty Liver: Cardiometabolic Complications and Challenges in NITsMarch 04, 2023
Episode artwork
S4-E10.1 - Increasing Incidence of Pediatric and Adolescent Fatty LiverMarch 04, 2023
Episode artwork
S4-E10 - Focus on Pediatric and Adolescent Fatty Liver DiseaseMarch 01, 2023
Episode artwork
S4-E9.5 - From the Vault: Discussing Comprehensive Care Models For NAFLD: Metrics, Key Performance Indicators and Improving ManagementFebruary 26, 2023
Episode artwork
S4-E9.4 - Combating Swelling NAFLD and NASH Prevalence: Drugs, Diagnostics and Guidelines for the FrontlineFebruary 26, 2023
Episode artwork
S4-E9.3 - Diabetes Drug Choices With Benefits For NAFLDFebruary 25, 2023
Episode artwork
S4-E9.2 - What’s Behind The New AACE Fatty Liver Guidelines?February 25, 2023
Episode artwork
S4-E9.1 - Growing NAFLD-Diabetes Dual Prevalence Increases CVD Risk for DiabeticsFebruary 25, 2023
Episode artwork